Two outer-membrane proteins (OMPs) of Pasteurella multocida serotype D, designated H and W, possess potentially important serotype D-specific antigens. Antigenicity as well as toxigenicity of 55 strains of R multocida representing various serotypes, geographic origins and host species were studied by SDS-PAGE, enzyme-linked immunosorbent assay (ELISA), immunoblot and polymerase chain reaction (PCR) assays. Based on the electrophoretic mobility of protein H, different OMP patterns were observed within different capsular serotypes. Three monoclonal antibodies (MAbs) designated MT1, MT2 and MT3 were produced against H and W proteins of R multocida in BALB/c mice. MAbs MT2 and MT3 reacted with two distinct epitopes on W protein of serotype D in competitive ELISA. MAb MT1 reacted with all serotype D-I strains but not with D-I1 strains, whereas MAb MT2 reacted with both serotype D-I and D-I1 strains in dot-ELISA and immunoblot assay. MAb MT3 reacted with all R multocida strains belonging to different capsular serotypes in dot-ELISA. None of the MAbs reacted with other gram-negative bacteria tested, indicating that protein H has a serotype D-I specific epitope and protein W has both serotype and species-specific epitopes. PCR assay was used to identify toxigenic strains of R multocida; 92% of R rnultocida strains possess both toxA gene and MAb MT2 reacting epitope, suggesting a strong association between MAb MT2 reacting epitopes and toxA gene. Rapid dot-ELISA with MAb was found to be specific, sensitive and easy to perform and thus suitable for routine serotyping of I! multocida serotype D strains which might be potentially pathogenic.
Introduction
Pasteurella multocida serotype D strains have been isolated from cattle, goats, rabbits, pigs, turkeys and man [l, 21. Some of the serotype D strains are toxigenic, causing atrophic rhinitis in calves, goats and pigs [3-61 and dermal lesions in poultry [7] . Several tests have been used to detect toxigenic P multocida strains, including the guinea-pig skin test [4] , cell culture assay [ 81, enzyme-linked immunosorbent assay (ELISA) [6, 9] and polymerase chain reaction (PCR) assay [ 10, 1 11 . The gene that encodes the toxin of P multocida, toxA, has been isolated and sequenced [ 121. PCR assay based on toxA 'gene has been shown to be a highly sensitive and specific assay for identification of toxigenic strains of P multocida [ [13, 181 , and 16 somatic serotypes, recognised by the GDP test [15] . Non-serological tests such as mucopolysaccharidase [2] and acriflavine [ 191 tests have also been developed for rapid identification of serotypes A, D and F strains of l? rnultocida. Serotyping of P multocida strains by current techniques produces ambiguous results [20] . It is difficult to prepare high-titre antisera against serotypes A and D specific antigens [ 181. Numerous strains which remain untypable have also been reported [20-231. Moreover, these tests are also known to give false-negative results with non-capsulate or less capsulate variants of l? multocida [17] . Thus, a more reliable method for serotyping of P multocida isolates needs to be developed. I? multocida serotype D strains were recently classified into two types (D-I and D-11) based on the electrophoretic mobility of two outer-membrane proteins (OMPs) (proteins H and W) and their reactivities with monoclonal antibodies (MAbs) [24, 25] . The purpose of this investigation was to develop a more precise and specific tool for routine typing of serotype D strains and to find out if there is any relationship between the presence of MAb-reacting epitopes and the toxA gene among l? multocida strains.
Materials and methods

Bacterial strains and culture conditions
The 55 strains of l? multocida representing various serotypes, geographic origins and animal species used in this study are listed in Table 1 A. pleuropneumoniae and H. injluenzae were grown on chocolate blood agar plates in air with C02 7%. C. jejuni was cultured on blood agar plates in a microaerophilic environment ( 0 2 5%). P multocida strains and all the other gram-negative bacteria were cultured aerobically on blood agar plates at 37°C for 24 h.
Preparation of OMPs
l? multocida strains of serotype A (1662, 2100, 4062), serotype B (656, 5325), serotype D (4065, 2153), serotype E (4096) and serotype F (4679 and 4218) were disrupted in a French press and Sarkosyl-insoluble OMPs were prepared as described previously [25, 26] . Sarkosyl-soluble OMPs of l? multocida serotypes B 656 and D 2153 were dialysed against Tris-HC1 (pH 7.8) and were treated with Triton X-100 (Sigma) 1% v/v in the presence of 10 mM MgC12 at room temperature for 1 h. After centrifugation, the Tritoninsoluble OMP preparation was resuspended in distilled water and stored at -20°C. The protein concentration was determined by the method of Bradford [27] .
Production of monoclonal and polyclonal antibodies
Three monoclonal antibodies (MAbs) designated MT 1, MT2 and MT3 were produced in BALB/c mice, with OMPs of serotypes D P210 or B 656 of l? multocida as described previously [24] . A MAb produced against Mycoplama gallisepticum (MAb Kl) was used as a negative control in competitive ELISA [28] . Polyclonal antibodies against the 32-kDa OMP (porin H) of l? multocida were produced in BALB/c mice, as described previously [25] . MAbs were purified from ascitic fluid with caprylic acid and ammonium sulphate as described by Ogden and Leung [29] . Proteinase-K and sodium periodate treatments of OMPs were performed as described previously [24] .
Epitope analysis by competitive ELISA
Competitive ELISA was performed as described previously [28] , in 96-well microtitration plates coated with Triton-insoluble OMPs of l? multocida serotype D 2153 as antigen, to analyse the epitope specificity of MAbs MT2 and MT3. Purified MAb MT2, at a protein concentration of 1 mg/ml, was biotinylated according to the manufacturer's instructions (Biotinylation kit, Amersham). It was used in a reciprocal competitive ELISA at a dilution of 1 in 1000 corresponding to an optical density (OD) of 1.0 at 405 nm. All incubations were at 37°C for 90 min, and dilutions and washings were performed in PBS-Tween (PBS-T). Ten-fold serial dilutions of the unlabelled competing homologous and heterologous MAbs were prepared. MAb against M. gallisepticum was used as a negative control. One hundred pl of MAbs in PBS-T were added to each well and incubated. After three washings and a further incubation with biotinylated MAb MT2, the plates were washed and incubated with an optimal dilution of streptavidin-peroxidase conjugate (BioRad). Finally, the plates were washed and developed for 30 min at room temperature in the dark with o-phenylenediamine (Sigma). The percentage of competition was calculated by the formula [lo0 ( An ) / A -B)]. A is the OD in the absence of competitor MAb (negative control MAb), n is the OD in the presence of heterologous competitor, and B is OD in the presence of homologous competitor. For the interpretation of results, < 30% competition was considered non-competitive, 30-70% was considered partially competitive and > 70% was considered fully competitive.
Rapid dot-ELISA
The spectrum of activity of MAbs with different l? multocida strains and other gram-negative organisms was tested by rapid dot-ELISA as described by Achacha and Mittal [30] . A 10-pl volume of optimally diluted boiled cell suspension was spotted on to a nitrocellulose membrane and allowed to dry at room temperature. The membrane was incubated with skim milk 5% v/v in PBS-T before incubation with MAb supernates for 1 h at room temperature. The blots were washed and incubated with goat anti-mouse horseradish peroxidase conjugate (BioRad) for 1 h at room temperature and washed. Membranes were developed in 4chloro-1 -naphthol substrate (BioRad) for 5-10 min, and the colour reaction was terminated by flooding the membrane with distilled water. Very strong binding, strong binding, distinct binding, weak binding and no binding of MAbs with antigens were recorded as 4+, 3+, 2+, 1+ andrespectively.
On: Tue, 11 Dec 2018 08:03:11
IDENTIFICATION OF l? MULTOCZDA BY MAbs
605
SDS-PAGE and immunoblot assay SDS-PAGE was performed by the method of Laemmli [3 11 with acrylamide 12% resolving gels. Immunoblot assay was performed by the method of Towbin [32] , as described previously by Vasfi Marandi et al. [25] .
Preparation of genomic DNA
Genomic DNA of 55 strains of P multocida was prepared by the method of Daigle et al. [33] . l? multocida strains were grown in brain-heart infusion broth at 37°C overnight. One ml of overnight culture was centrifuged at 18 000 g for 10 min. The sediment was suspended in 200 pl of sterile water and boiled for 10 min at 100°C. After centrifugation of the lysate, a 150-pl sample of the supernate was stored at -20°C as a template DNA stock.
PCR ampllJcation of toxA gene
Two oligonucleotide primers with the following sequences were synthesised on a Gene Assembler The reaction mixture consisted of 1 p~ of each oligonucleotide primer, 200 ,UM each of dATP, dCTP, dGTP and dTTP, 1 unit of Taq DNA polymerase (Gibco BRL, Burlington, Canada), 5 pl of 10 X reaction buffer (1.5 mM MgC12, 10 mM Tris HCl, pH 8.4, 50 mM KCl, glycerol 4%) and 10 pl of sample DNA, The reaction mixture was covered with a drop of mineral oil and was subjected to 25 cycles of 1 min at 92"C, 1 min at 55"C, and 2 min at 70°C in a Thermal Cycler (Perkin Elmer Cetus, Canada). A toxigenic serotype D strain 4-4056 and non-toxigenic serotype A strain X-73 were used as controls. A negative control without DNA was also included in each run. Ten pl of the amplification products were separated by electrophoresis in agarose 1.2% gels (Gibco BRL), and the DNA fragment was visualised by UV fluorescence after straining with ethidium bromide 0.5 pglml. A 1-kb DNA ladder (Gibco BRL) was used as a size marker in all gels.
Results
W protein of I! multocida
Two MAbs designated MT2 and MT3 were produced with OMP preparations of I! multocida serotype D P210 and B 656 respectively. In immunoblot assay, both MAbs MT2 and MT3 reacted with a 32-kDa OMP of l? multocida serotype D 2153 (Fig. 1) . The epitopes reactive with MAb MT2 were sensitive to treatment with both proteinase K and sodium periodate whereas those reactive with MAb MT3 were sensitive to treatment with proteinase K but not sodium periodate. The results of competitive ELISA showed that there was no competition (< 10%) between the two MAbs MT2 and MT3 (Fig. 2 ).
SDS-PAGE analysis of H protein of II multocida
Sarkosyl-insoluble OMPs or whole-cell proteins of 5 5 strains of P multocida were analysed by SDS-PAGE. Based on the migration of the major OMP (porin H), three OMP patterns within serotype A (A-I, A-I1 and A-111), two within serotype B (B-1 and B-11), two within serotype D (D-I and D-11) and two within serotype F (F-I and F-11) were observed. No heterogeneity was found among three strains of serotype E tested. Polyclonal antibodies directed against the 32-kDa porin H of I! multocida reacted with the major OMPs of all I! multocida strains tested in immunoblot assay ( Fig. 3 , Table 1 ).
Serospecificity of MAbs
The 55 strains of I! multocida and 17 other gramnegative bacteria were tested for reactivity with MAbs MT1, MT2 and MT3 by dot-ELISA and immunoblot assay. MAb MT1 directed against the 32-kDa porin of P multocida reacted only with serotype D-I strains; 90% of serotype D strains (D-I and D-11) reacted with MAb MT2. However, two serotype A strains (1702, 2305A) and some of the untypable strains also reacted with MAb MT2. None of the serotype B, E and F strains reacted with MAbs MT1 and MT2. There was 100% correlation between results obtained with dot-ELISA and immunoblot assay. MAb MT3 reacted with all 55 strains of I! multocida in dot-ELISA. However, three strains (4399, 4096 and 4679) failed to react in immunoblot assay. MAb MT3 reacted more strongly with serotype D strains than with other serotypes of l? multocida strains in dot-ELISA (Table 1) . 
PCR amplification of toxA gene
PCR assay was used to discriminate between toxigenic and non-toxigenic I! multocida strains tested. For PCR amplification, two oligonucleotide primers were chosen on the basis of the sensitivity and specificity obtained when used in PCR. These primers were located around the 1.5-kb HindIII-Hind111 fragment of the toxA gene IP: 54.70.40.11
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**toxA gene was amplified with specific primers and 1.5-kb amplified product was electrophoresed in agarose 1.2% gel. because the amplified product of this fragment has been clearly detected by agarose gel electrophoresis [ll]. The toxA gene was detected in 13 (65%) of 20 serotype D, 1 (5.6%) of 18 serotype A and 1 (20%) of five untypable strains of I? multocida. The toxA gene was not detected among any of the serotype B, E and F strains of I? multocida (Fig. 4) . No relationship was found between serotype D-I or D-I1 strains and presence of toxA gene. However, 92% of I? multocida strains with the toxA gene possessed a MAb MT2reacting epitope (Table 1 ).
Discussion
Serological diagnosis and vaccination programmes have been used in attempts to control various animal diseases. All these programmes require an extensive knowledge of different serotypes prevalent in the particular region. l? multocida is known to be an antigenically heterogeneous pathogen that causes various septicaemic or respiratory diseases in domestic and wild animals and man [ 1, 2] . The heterogeneity of this species is evident from the fact that five distinct capsular serotypes [13, 181 and 16 somatic serotypes [15] have been identified. Serotyping of P multocida strains by current techniques may produce ambiguous results [20] .
It was reported earlier that a MAb (MT2) directed against the 32-kDa OMP (W protein) of I? multocida serotype D P210 may be potentially useful for identifying serotype D strains [24] . In the present study, another MAb (MT3) was produced against the W protein of 19 multocida 656. Results obtained with competitive ELISA and immunoblot assay showed that both MAbs MT2 and MT3 were directed against two distinct epitopes of the W protein. MAb MT2 reacted with 90% of serotype D and 80% of untypable strains in dot-ELISA and immunoblot assay, whereas MAb MT3 reacted with I! multocida strains belonging to all serotypes. MAbs MT2 and MT3 did not react with other gram-negative bacteria, suggesting that MAbs MT2 and MT3 were directed against serotype and species-specific epitopes on W protein, respectively. Both MAbs reacted more intensely with serotype D strains in dot-ELISA than with strains belonging to other serotypes. Seemingly, this may be due to the high expression of the 32-kDa OMP (W protein) in serotype D strains. MAb MT2 recognised both capsulate strains (4275, 4533 and 4884) and their non-capsulate variants (4275B, 4533B and 4884B) of serotype D of 19 multocida. This observation may be potentially useful especially considering that noncapsulate or less capsulate strains cannot be identified by either IHA or the acriflavine test [ 171. MAb-based rapid dot-ELISA was found to be specific, sensitive and easy to perform, for routine serotyping and epidemiological study of both capsulate and non capsulate variants of serotype D strains.
In a previous study, based on the migration of proteins H and W in SDS-PAGE and their reactivities with MAbs MT1 and MT2, serotype D strains of 19 multocida were classified into two groups (D-I and D-11). In this study, two serotype A strains reacted with MAb MT1 or MT2; however, two serotype D strains did not react with MAb MT2. To explain such discrepancy, porin H of all 55 P multocida strains was compared in SDS-PAGE as well as in immunoblot assay with monoclonal and polyclonal antibodies. In view of the fact that serotype A strain 1702 bearing 37-kDa porin H reacted with MAb MT2 and serotype A strain 2305A bearing 32-kDa porin H reacted with both MAbs MTl and MT2, and the serotype D stiains 4886 and 4399 bearing 36-and 39-kDa porin H, respectively, failed to react with both MAbs MTl and MT2, it is suggested that in this serotyping system based on OMP patterns, MAb MT2-reacting serotype A strains may belong to the same serotype as MAb MT2-reacting serotype D strains, whereas serotype D strains which failed to react with MAb MT2 may belong to another serotype. Some gram-negative bacterial porins are involved in protection against infection [34] . As different OMP patterns, based on the electrophoretic mobility of porin H, were detected among I! multocida strains belonging to the same capsular serotype (Fig. 3) , it is suggested that the strains with different OMP patterns should be incorporated in a multivalent vaccine for effective protection against pasteurellosis.
To find an eventual relationship between toxigenic strains and those carrying MAbs MT1-or MT2reacting epitopes, the present study proceeded to differentiate toxigenic and non-toxigenic strains by PCR to select the toxA sequence. The toxA gene was detected among serotype D strains, in one serotype A strain and in one untypable strain but not in strains belonging to other serotypes. As 92% of I! multocida strains possessing the toxA gene expressed the MAb MT2-reacting epitope, there seems to be a strong association between the presence of MAb MT2reacting antigen and toxA gene. Kamps et al. [35] reported that some non-toxigenic strains of 19 multocida might have an incomplete or highly mutated toxA gene. Hare1 et al. [5] showed a similarity between DNA fingerprinting of toxigenic and some non-toxigenic strains and suggested that the inability of some of the non-toxigenic strains to produce toxin may be related to subtle differences at the chromosomal DNA level.
Although serotype-specific somatic antigens of I! multocida have been well characterised and are considered to be lipopolysaccharide (LPS) components of the heat-stable antigens [36] , serotypespecific capsular antigens of I! multocida have not yet been well characterised. Some investigators have demonstrated that the major antigen involved in the IHA of capsular serotyping was LPS [37] , and other workers have shown that capsular polysaccharides, rather than LPS, confer serotype specificity [38] . Rimler et al. [39] showed that the capsule of 19 multocida serotype A, D and F strains contain mucopolysaccharides that block antigenic determinants involved in IHA test. Recently it was shown that serotype D specific antigen of I! multocida may be a glycoprotein which is masked by capsule [24] .
As 90%of capsular serotype D strains possessed MAb MT2-reacting epitopes which are of glycoprotein nature, it is possible that the antigen involved in the capsular serotyping system may be glycoprotein rather than LPS or capsular polysaccharide. The biological role of serotype D specific antigen has not been studied. However, the a-complex antigen of 19 multocida serotype B described by Prince and Smith [40] was immunogenic for cattle and closely bound to the cell envelope. It probably consists of proteinpolysaccharide complex [4 11 . A protective antigen extracted from the turkey pathogenic strain of P multocida serotype A contains three protein subunits, as well as one carbohydrate band [42] , or a glycoprotein-like antigen [43] . More recently, Rimler [44] reported that the membrane associated proteincarbohydrate antigens of the turkey isolate of 19 multocida may contribute to immune cross-protection. Further studies are needed to demonstrate antigenic relationships between 32-kDa serotype D specific glycoprotein (W protein) and protective proteinpolysaccharide antigens described for serotypes A and B strains of I! multocida.
